🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 1 día
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
16/05/2011 2,5000 EUR
20/05/2010 2,4000 EUR
23/04/2009 2,2000 EUR
16/05/2008 2,0700 EUR
07/06/2007 1,7500 EUR
29/11/2006 0,2668 EUR
07/06/2006 1,5200 EUR
29/11/2005 0,2409 EUR
07/06/2005 1,2000 EUR
30/09/2004 0,0750 EUR
05/05/2004 1,4550 EUR
02/06/2003 0,8400 EUR
03/06/2002 0,6600 EUR
01/06/2001 0,4400 EUR
05/06/2000 0,3200 EUR
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/03/2024 88,16 89,35 88,16 88,20 -0,01% 1,35% 3.106.988
14/03/2024 88,92 89,47 88,02 88,21 -0,32% 1,63% 1.249.466
13/03/2024 88,80 88,80 87,85 88,49 +0,17% 1,07% 1.017.214
12/03/2024 88,87 88,90 88,02 88,34 +0,02% 0,99% 1.131.977
11/03/2024 88,59 89,18 88,02 88,32 +0,72% 1,31% 946.037
08/03/2024 87,78 87,95 87,35 87,69 -0,35% 0,68% 1.023.894
07/03/2024 87,16 88,38 86,90 88,00 +1,01% 1,70% 1.431.624
06/03/2024 87,62 87,76 86,75 87,12 -0,55% 1,15% 892.841
05/03/2024 87,68 88,22 87,41 87,60 +0,90% 0,92% 1.114.425
04/03/2024 87,57 87,80 86,20 86,82 -0,56% 1,83% 896.675
01/03/2024 88,45 88,52 87,09 87,31 -0,66% 1,62% 1.585.969
29/02/2024 88,61 89,23 87,88 87,89 -1,07% 1,52% 2.894.359
28/02/2024 88,96 89,53 88,70 88,84 +0,01% 0,93% 786.462
27/02/2024 88,35 89,19 88,27 88,83 -0,50% 1,04% 965.027
26/02/2024 90,34 90,42 89,28 89,28 -0,48% 1,26% 1.100.611
23/02/2024 88,86 89,81 88,48 89,71 +1,09% 1,50% 1.242.118
22/02/2024 88,20 89,04 87,92 88,74 +1,57% 1,27% 1.634.926
21/02/2024 86,70 87,52 86,05 87,37 +0,28% 1,70% 1.287.552
20/02/2024 86,06 88,99 86,03 87,13 +1,06% 3,44% 2.181.693
19/02/2024 86,18 86,88 85,96 86,22 -0,28% 1,07% 747.978
16/02/2024 86,29 86,66 85,63 86,46 -0,06% 1,19% 1.182.545
15/02/2024 85,34 86,62 85,03 86,51 +0,91% 1,86% 1.494.158
14/02/2024 85,50 85,73 84,93 85,73 +0,05% 0,94% 1.124.324
13/02/2024 86,00 86,60 85,52 85,69 -0,44% 1,26% 1.100.728
12/02/2024 85,86 86,20 85,51 86,07 -0,50% 0,80% 1.164.123
09/02/2024 86,70 87,11 85,97 86,50 +0,83% 1,31% 1.366.254
08/02/2024 87,13 87,13 85,51 85,79 -1,83% 1,86% 1.299.894
07/02/2024 87,87 88,16 87,08 87,39 +0,18% 1,23% 1.121.528
06/02/2024 87,09 87,55 86,47 87,23 -0,19% 1,24% 1.194.411
05/02/2024 87,44 87,80 86,97 87,40 -0,19% 0,95% 1.285.472